Salpingectomy as a Means to Reduce Ovarian Cancer Risk

被引:53
作者
Daly, Mary B. [1 ]
Dresher, Charles W. [2 ]
Yates, Melinda S. [3 ]
Jeter, Joanne M. [4 ]
Karlan, Beth Y. [5 ]
Alberts, David S. [6 ]
Lu, Karen H. [3 ]
机构
[1] Fox Chase Canc Ctr, Dept Clin Genet, Philadelphia, PA 19111 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, Dept Translat Outcomes Res Grp, Seattle, WA 98104 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[4] Univ Arizona, Dept Med, Tucson, AZ USA
[5] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA
[6] Univ Arizona, Ctr Canc, Tucson, AZ USA
关键词
BRCA2 MUTATION CARRIERS; HORMONE REPLACEMENT THERAPY; ORAL-CONTRACEPTIVE USE; QUALITY-OF-LIFE; BREAST-CANCER; PROPHYLACTIC OOPHORECTOMY; SEROUS CARCINOMA; TUBAL-LIGATION; INTRAEPITHELIAL CARCINOMA; CARDIOVASCULAR-DISEASE;
D O I
10.1158/1940-6207.CAPR-14-0293
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Bilateral salpingo-oophorectomy (BSO) has become the standard-of-care for risk reduction in women at hereditary risk of ovarian cancer. Although this procedure significantly decreases both the incidence of and mortality from ovarian cancer, it affects quality of life, and the premature cessation of ovarian function may have long-term health hazards. Recent advances in our understanding of the molecular pathways of ovarian cancer point to the fallopian tube epithelium as the origin of most high-grade serous cancers (HGSC). This evolving appreciation of the role of the fallopian tube in HGSC has led to the consideration of salpingectomy alone as an option for risk management, especially in premenopausal women. In addition, it is postulated that bilateral salpingectomy with ovarian retention (BSOR), may have a public health benefit for women under going benign gynecologic surgery. In this review, we provide the rationale for salpingectomy as an ovarian cancer risk reduction strategy. (C) 2015 AACR.
引用
收藏
页码:342 / 348
页数:7
相关论文
共 72 条
[1]
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[2]
[Anonymous], 2009, Obstet Gynecol, V113, P957, DOI DOI 10.1097/AOG.0B013E3181A106D4
[3]
[Anonymous], IARC CANC BASE
[4]
[Anonymous], SCREEN OV CANC CLIN
[5]
Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study [J].
Antoniou, Antonis C. ;
Rookus, Matti ;
Andrieu, Nadine ;
Brohet, Richard ;
Chang-Claude, Jenny ;
Peock, Susan ;
Cook, Margaret ;
Evans, D. Gareth ;
Eeles, Rosalind ;
Nogues, Catherine ;
Faivre, Laurence ;
Gesta, Paul ;
van Leeuwen, Flora E. ;
Ausems, Margreet G. E. M. ;
Sorio, Ana ;
Caldes, Trinidad ;
Simard, Jacques ;
Lubinski, Jan ;
Gerdes, Anne-Marie ;
Olah, Edith ;
Fuerhauser, Christine ;
Olsson, Hakan ;
Arver, Brita ;
Radice, Paolo ;
Easton, Douglas F. ;
Goldgarl, David E. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) :601-610
[6]
Arnold AG, 2009, CURR BREAST CANCER R, V1, P157, DOI 10.1007/s12609-009-0022-4
[7]
Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis [J].
Atsma, F ;
Bartelink, MLEL ;
Grobbee, DE ;
van der Schouw, YT .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (02) :265-279
[8]
Baldwin RL, 2000, CANCER RES, V60, P5329
[9]
The biology of ovarian cancer: new opportunities for translation [J].
Bast, Robert C., Jr. ;
Hennessy, Bryan ;
Mills, Gordon B. .
NATURE REVIEWS CANCER, 2009, 9 (06) :415-428
[10]
Brinton L, 2013, PRINCIPLES PRACTICE, V6, P1